Pancreatic Cancer Guidelines Nccn
Formatting was changed throughout the guideline for consistency.
Pancreatic cancer guidelines nccn. Updates in version 1 2020 of the nccn guidelines for pancreatic adenocarcinoma from version 3 2019 include. The state of cancer care in america. The national comprehensive cancer network. The nccn templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the nccn guidelines or the nccn compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer.
Based on better understanding of the molecular basis of pancreatic cancer and on encouraging outcomes from clinical trials the nccn guidelines recommend that clinicians consider germline testing in any patient diagnosed with pancreatic cancer and consider a molecular analysis of tumors in those with metastatic disease. Recent advances and changes to the nccn guidelines.